Companies
-
MSD in $2B autoimmune buy
- 01 Mar 2021
Adding phase 1 investigative therapy to its pipeline.
Read more -
Vertex steps up to the plate
- 18 Feb 2021
With all bases loaded, can Vertex score a home run with Trikafta?
Read more -
Pfizer recovers from PBS slump
- 03 Feb 2021
Former darling of the PBS is rediscovering its mojo.
Read more -
ACCC targets Aussie pharmaco
- 28 Jan 2021
Local meds maker facing up to $10m fine as regulator takes court action.
Read more -
GSK global tops for meds access
- 27 Jan 2021
Pharmas credited for meds access in poorer countries.
Read more -
Soriot quits CSL Board
- 27 Jan 2020
Cites ‘potential future conflict of strategic interest’ following Alexion buyout.
Read more